NSE:MEDPLUS
MedPlus Health Services Limited
- Stock
Last Close
806.15
02/05 08:51
Market Cap
79.86B
Beta: -
Volume Today
71.84K
Avg: 127.36K
PE Ratio
138.97
PFCF: 366.32
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 5.19B - | 6.97B 34.30% | 8.32B 19.48% | 10.30B 23.67% | 12.42B 20.65% | 13.43B 8.09% | ||
average payables | 1.96B - | 1.91B 2.56% | 1.97B 3.16% | 2.53B 28.41% | 2.57B 1.34% | 2.76B 7.56% | ||
average receivables | 190.39M - | 234.40M 23.11% | 130.78M 44.21% | 153.88M 17.66% | ||||
book value per share | 24.42 - | 44.24 81.17% | 61.23 38.41% | 126.54 106.65% | 124.96 1.25% | 132.02 5.65% | ||
capex per share | -1.82 - | -2.53 38.86% | -4.55 79.60% | -10.51 131.03% | -14.16 34.79% | 7.06 149.88% | ||
capex to depreciation | -0.37 - | -0.40 8.77% | -0.61 52.08% | -0.99 60.58% | -0.93 5.87% | 0.38 140.54% | 0.24 36.79% | |
capex to operating cash flow | -0.15 - | 4.59 3,191.36% | -18.77 509.33% | -0.69 96.31% | -1.87 169.77% | 0.59 131.41% | 0.11 81.74% | |
capex to revenue | -0.01 - | -0.01 10.01% | -0.02 67.85% | -0.03 76.26% | -0.04 18.29% | 0.02 140.46% | 0.01 35.43% | |
cash per share | 4.18 - | 11.81 182.42% | 12.50 5.81% | 58.69 369.51% | 24.82 57.72% | 13.81 44.34% | ||
days of inventory on hand | 77.95 - | 100.48 28.90% | 112.88 12.34% | 111.98 0.80% | 117.38 4.82% | 110.91 5.51% | 87.41 21.19% | |
days payables outstanding | 31.28 - | 36.56 16.88% | 22.29 39.03% | 30.14 35.19% | 26.69 11.43% | 20.94 21.54% | 19.43 7.22% | |
days sales outstanding | 3.70 - | 0.70 80.96% | 1.14 61.15% | 0.79 30.50% | ||||
debt to assets | 0.45 - | 0.35 20.83% | 0.38 6.52% | 0.31 16.66% | 0.32 2.43% | 0.33 - | ||
debt to equity | 1.47 - | 0.90 38.52% | 0.81 10.66% | 0.57 28.85% | 0.60 4.99% | 0.64 - | ||
dividend yield | - | |||||||
earnings yield | 0.00 - | 0.00 81.71% | 0.00 2,829.27% | 0.01 76.54% | 0.01 23.85% | 0.01 22.32% | InfinityT Infinity% | |
enterprise value | 137.79B - | 137.39B 0.29% | 138.59B 0.87% | 121.60B 12.26% | 84.25B 30.72% | 92.58B 9.89% | 7.53B 91.87% | |
enterprise value over ebitda | 105.48 - | 75.30 28.61% | 59.07 21.55% | 40.53 31.39% | 26.98 33.42% | 23.49 12.94% | 1.40 94.02% | |
ev to operating cash flow | 93.94 - | -2.09K 2,319.72% | 4.79K 329.91% | 71.58 98.51% | 93.18 30.19% | 64.41 30.88% | 1.36 97.89% | |
ev to sales | 6.10 - | 4.82 21.01% | 4.54 5.72% | 3.24 28.72% | 1.85 42.91% | 1.65 10.96% | 0.12 92.55% | |
free cash flow per share | 10.47 - | -3.08 129.46% | -4.31 39.58% | 4.66 208.14% | -6.59 241.45% | 4.97 175.41% | ||
free cash flow yield | 0.01 - | -0.00 129.46% | -0.00 39.58% | 0.00 219.51% | -0.01 320.88% | 0.01 170.19% | ||
graham net net | -35.24 - | -29.91 15.12% | -26.02 13.01% | -2.96 88.62% | -36.15 1,121.12% | -48.48 34.08% | ||
graham number | 23.43 - | 13.49 42.44% | 85.87 536.75% | 156.02 81.69% | 108.28 30.60% | 127.61 17.85% | ||
income quality | 6.45 - | -0.22 103.48% | 0.03 113.55% | 1.44 4,638.23% | 1.92 33.08% | 2.20 14.52% | 3.69 68.00% | |
intangibles to total assets | 0.04 - | 0.03 24.35% | 0.03 14.08% | 0.02 36.40% | 0.02 4.75% | 0.02 2.10% | 0.02 11.68% | |
interest coverage | 1.29 - | 2.34 80.90% | 2.73 16.75% | 2.72 0.30% | 1.57 42.35% | 5.84 272.67% | 2.31 60.42% | |
interest debt per share | 39.94 - | 43.87 9.82% | 53.96 23.02% | 78.66 45.77% | 82.37 4.71% | 8.07 90.20% | ||
inventory turnover | 4.68 - | 3.63 22.42% | 3.23 10.99% | 3.26 0.80% | 3.11 4.60% | 3.29 5.83% | 4.18 26.88% | |
invested capital | 1.47 - | 0.90 38.52% | 0.81 10.66% | 0.57 28.85% | 0.60 4.99% | 22.96B 3,804,206,968,990.72% | 25.80B 12.36% | |
market cap | 133.76B - | 133.76B 0% | 133.76B 0% | 113.67B 15.02% | 77.53B 31.79% | 83.39B 7.56% | ||
net current asset value | -1.98B - | -38.17M 98.07% | 885.22M 2,419.15% | 4.55B 413.90% | 1.75B 61.64% | 1.40B 19.71% | 2.23B 59.39% | |
net debt to ebitda | 3.09 - | 1.99 35.52% | 2.06 3.46% | 2.64 28.35% | 2.15 18.67% | 2.33 8.34% | 1.40 39.72% | |
net income per share | 1.00 - | 0.18 81.71% | 5.35 2,829.27% | 8.55 59.75% | 4.17 51.23% | 5.48 31.41% | ||
operating cash flow per share | 12.29 - | -0.55 104.49% | 0.24 143.88% | 15.16 6,157.33% | 7.58 50.03% | 12.03 58.80% | ||
payables turnover | 11.67 - | 9.98 14.44% | 16.37 64.01% | 12.11 26.03% | 13.68 12.91% | 17.43 27.45% | 18.79 7.78% | |
receivables turnover | 98.62 - | 517.85 425.08% | 321.35 37.95% | 462.37 43.88% | ||||
research and ddevelopement to revenue | 0.00 - | 0.00 35.20% | 0.00 20.92% | |||||
return on tangible assets | 0.01 - | 0.00 87.15% | 0.04 2,411.02% | 0.04 10.42% | 0.02 51.86% | 0.02 22.41% | 0.05 104.90% | |
revenue per share | 189.33 - | 238.99 26.22% | 255.71 7.00% | 335.17 31.07% | 381.91 13.95% | 470.79 23.27% | ||
roe | 0.04 - | 0.00 89.91% | 0.09 2,016.30% | 0.07 22.70% | 0.03 50.61% | 0.04 24.34% | 0.09 108.14% | |
roic | 0.03 - | 0.00 84.65% | 0.05 1,044.58% | 0.05 8.63% | 0.04 15.86% | 0.32 658.74% | 0.07 78.94% | |
sales general and administrative to revenue | 0.01 - | 0.00 36.02% | 0.00 20.98% | 0.00 3.18% | 0.00 2.28% | 0.11 2,319.27% | ||
shareholders equity per share | 24.42 - | 44.24 81.17% | 61.23 38.41% | 126.54 106.65% | 124.96 1.25% | 132.07 5.69% | ||
stock based compensation to revenue | 0.00 - | 0.00 97.73% | 0.01 49,040.24% | 0.00 78.17% | 0.00 69.75% | 0.00 48.33% | ||
tangible asset value | 2.49B - | 4.84B 94.49% | 6.86B 41.79% | 13.70B 99.69% | 14.42B 5.25% | 15.26B 5.85% | 16.89B 10.69% | |
tangible book value per share | 20.85 - | 40.54 94.49% | 57.49 41.79% | 122.23 112.63% | 120.79 1.18% | 127.71 5.72% | ||
working capital | 971.98M - | 3.35B 244.34% | 5.08B 51.82% | 10.73B 111.10% | 10.04B 6.39% | 10.42B 3.73% | 12.67B 21.63% |
All numbers in INR (except ratios and percentages)